首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

市場調查報告書

商品編碼

1455146

全球深層腦部刺激器市場規模、佔有率、成長分析（按產品類型、按應用、按最終用戶）- 產業預測，2024-2031 年

Global Deep Brain Stimulation Devices Market Size, Share, Growth Analysis, By Product Type, By Application, By End-user - Industry Forecast 2024-2031

出版日期: 2024年03月20日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球深層腦部刺激器市場規模預估為14.1億美元，從2023年的15.4億美元成長到2031年為31.4億美元，預測期間（2024-2031年）複合年成長率為9.29%。

由於許多重要的考慮因素，深層腦部刺激器市場在全球範圍內顯著成長。隨著自發性震顫、帕金森氏症和肌張力不全症等神經系統疾病變得越來越常見，對深層腦部刺激器的需求也隨之增加。目前，全球醫療保健系統承受著神經系統疾病的沉重負擔，這使得深部腦部刺激成為最有效的治療方法之一。深層腦部刺激器技術的進步正在改善患者的治療效果並擴大應用範圍。更持久的充電電池、更好的瞄準系統和改進的刺激參數等技術創新使深部腦部刺激治療更安全、更有效。由於患者和醫療保健專業人員越來越意識到深部腦部刺激是一種有效的治療選擇，因此市場正在擴大。深部腦部刺激因其許多好處而變得越來越普及，包括提高生活品質、減少對藥物的依賴和緩解症狀。新興市場有利的報銷政策也有助於市場開拓。由於醫療成本上升和醫療基礎設施的改善，深部腦部刺激設備製造商看到了擴大新興國家市場佔有率的巨大潛力。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Medtronic plc（Ireland）
Boston Scientific Corporation（US）
Abbott Laboratories（US）
LivaNova PLC（UK）
Sapiens Neuro（US）
Beijing PINS Medical Co., Ltd.（China）
SceneRay Corporation（China）
Nevro Corp.（US）
Aleva Neurotherapeutics SA（Switzerland）
Functional Neuromodulation Ltd.（Canada）
NeuroPace, Inc.（US）
Neuronetics, Inc.（US）
Brainsway Ltd.（Israel）
Synaptive Medical Inc.（Canada）
Alpha Omega Engineering Ltd.（Israel）
Nexeon MedSystems, Inc.（US）
Autonomix Medical, Inc.（US）
Greatbatch Medical（US）
SceneRay Corp.（China）
Saluda Medical Pty Ltd.（Australia）

簡介目錄

Product Code: SQMIG35G2217

Global Deep Brain Stimulation Devices Market size was valued at USD 1.41 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 3.14 billion by 2031, at a CAGR of 9.29% during the forecast period (2024-2031).

The market for deep brain stimulation devices is expanding significantly on a global scale due to numerous important considerations. The need for deep brain stimulation devices is growing as neurological conditions such essential tremor, Parkinson's disease, and dystonia become more common. Worldwide healthcare systems are now heavily burdened by neurological illnesses, which makes deep brain stimulation one of the most effective therapy choices available. Deep brain stimulation device technology has advanced, improving patient outcomes and expanding applications. Deep brain stimulation operations are now safer and more effective thanks to innovations like longer-lasting rechargeable batteries, better targeting systems, and improved stimulation parameters. The market is expanding as a result of patients' and healthcare professionals' rising awareness of deep brain stimulation as an effective therapeutic option. Deep brain stimulation is becoming more and more popular because of its many advantages, which include better quality of life, less reliance on medication, and symptom relief. Market expansion is also being aided by developed areas' advantageous reimbursement policies. Deep brain stimulation device manufacturers are seeing great potential to grow their market share in emerging economies due to rising healthcare costs and bettering healthcare infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segmental Analysis

Based on product type, application, end-user, and geography, the global market for deep brain stimulation devices may be divided. The market can be divided into rechargeable and non-rechargeable DBS devices based on the type of product. The market can be divided into segments according to application, such as essential tremor, dystonia, and Parkinson's disease. The market can be divided into hospitals, ambulatory surgery centers, and specialty clinics based on the end-user. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Deep Brain Stimulation Devices Market

Technological advancements in deep brain stimulation have improved patient results, increased the number of disorders that can be treated, and increased the therapy's overall efficacy and safety. Improved stimulation parameters, more accurate targeting systems, and the incorporation of sophisticated features like closed-loop systems and adaptive algorithms are examples of technological breakthroughs. These developments allow for more individualized treatment plans, improved symptom control, and fewer adverse effects.

Restraints in the Global Deep Brain Stimulation Devices Market

Because deep brain stimulation devices are intricate, expert neurosurgeons must undertake precise insertion procedures. These devices can have high costs associated with them, especially for the programming systems, leads, and hardware. The expense of the surgical treatment itself is further increased by the requirement for specialist equipment, resources in the operating room, and post-operative care. The high price makes it difficult to purchase and accessible, especially in areas with few healthcare services or insufficient insurance coverage.

Market Trends of the Global Deep Brain Stimulation Devices Market

The demand is being driven by the rising prevalence of neurological disorders: A surgical technique called deep brain stimulation (DBS) employs electrical stimulation to treat a range of neurological conditions, such as dystonia, essential tremor, and Parkinson's disease. The aging population, the rise in chronic illnesses, and the accumulation of environmental pollutants are some of the causes of this increase in prevalence. Since DBS devices are a highly successful treatment for many neurological disorders, the demand for them is being driven by the rising prevalence of these conditions.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Deep Brain Stimulation Devices Market by Product Type

Market Overview
Rechargeable DBS devices
non-rechargeable DBS devices

Global Deep Brain Stimulation Devices Market by Application

Market Overview
Parkinson's disease
essential tremor
dystonia

Global Deep Brain Stimulation Devices Market by End-user

Market Overview
Hospitals
ambulatory surgical centers
and specialty clinics

Global Deep Brain Stimulation Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sapiens Neuro (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing PINS Medical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SceneRay Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Functional Neuromodulation Ltd. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainsway Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synaptive Medical Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alpha Omega Engineering Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexeon MedSystems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Autonomix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greatbatch Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SceneRay Corp. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Saluda Medical Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments